Platelets from thrombocytopenic ponies acutely infected with equine infectious anemia virus are activated in vivo and hypofunctional.

This research focuses on understanding thrombocytopenia, or low platelet count, in ponies caused by an infection with equine infectious anemia virus (EIAV). The study shows that while this infection leads to an increase in large, immature platelets and increased activation of these platelets, it does not severely inhibit platelet production.

Thrombocytopenia in Horses due to EIAV Infection

• The study began by acknowledging that thrombocytopenia, a condition characterized by abnormally low amounts of platelets, is a consistent and early finding in horses infected with EIAV. EIAV is a virus similar to the human immunodeficiency virus (HIV).
• The research aims to determine whether the process of platelet production (regenerative thrombopoiesis) and platelet destruction are ongoing in ponies suffering from an acute infection of EIAV.

Findings about Platelet Count and Activity

• The researchers found an increase in large, immature platelets late in the infection, when the platelet count was at its lowest. This suggests an ongoing process of regenerative thrombopoiesis.
• Upon examining the bone marrow from the infected ponies, the research noted an increase in megakaryocyte area and megakaryocyte nuclear area. Megakaryocytes are the cells responsible for producing platelets, so an increasing size indicates an effort to produce more platelets.
• There was also a trend towards an increased number of megakaryocytes, further supporting the idea that platelet production was not severely harmed by the infection.

Platelet Activation and Functionality

• The research found that platelets from infected ponies had increased levels of surface-bound fibrinogen, a protein that helps in clot formation, and showed other changes that are consistent with platelet activation.
• However, these platelets displayed a decreased functional response, or hypofunctionality, to certain agonists in lab tests. This means that although the platelets were activated and ready to help clot blood, they weren’t performing as well as expected.
• The researchers argue that this hypofunctionality may stem from the platelets’ in vivo activation causing platelet degranulation (release of granules from the cells) or formation of platelet aggregates (clumps of platelets), which would then be removed from circulation.

Conclusion

• The researchers proposed that this process might be a form of nonimmune-mediated platelet destruction, as it doesn’t involve the body’s immune response actively destroying the platelets.
• They conclude that thrombocytopenia in ponies acutely infected with EIAV is regenerative, meaning that the body is able to continue producing new platelets despite the infection. However, the activation of platelets in vivo results in hypofunctionality, which may contribute to their subsequent destruction and removal from circulation.